Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2019

01-08-2019 | Computed Tomography | Case Report

Hepatic portal venous gas associated with Klebsiella oxytoca infection in the absence of preceding antibiotic treatment

Published in: Clinical Journal of Gastroenterology | Issue 4/2019

Login to get access

Abstract

Klebsiella oxytoca (K. oxytoca) is a causative organism for hemorrhagic antibiotic-associated colitis. K. oxytoca infection is a typical example of microbial substitution diseases caused by exposure to antibiotics prior to the onset of diarrhea. Here, we repot a case with ileitis associated with K. oxytoca infection in the absence of preceding antibiotic treatment. Interestingly, abdominal computed tomography revealed wall thickening of the ileum and hepatic portal venous gas (HPVG). K. oxytoca was isolated from the stool. This very elderly patient had been treated with azathioprine for long-standing history of ulcerative colitis. Immuno-compromised state of this patient was considered to allow overgrowth of K. oxytoca in the small bowel to cause not only ileitis but also HPVG.
Literature
1.
go back to reference Joainig MM, Gorkiewicz G, Leitner E, et al. Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with antibiotic-associated hemorrhagic colitis or other diseases caused by infections and from healthy subjects. J Clin Microbiol. 2010;48:817–24.CrossRefPubMedPubMedCentral Joainig MM, Gorkiewicz G, Leitner E, et al. Cytotoxic effects of Klebsiella oxytoca strains isolated from patients with antibiotic-associated hemorrhagic colitis or other diseases caused by infections and from healthy subjects. J Clin Microbiol. 2010;48:817–24.CrossRefPubMedPubMedCentral
2.
go back to reference Schneditz G, Rentner J, Roier S, et al. Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis. Proc Natl Acad Sci USA. 2014;111:13181–6.CrossRefPubMed Schneditz G, Rentner J, Roier S, et al. Enterotoxicity of a nonribosomal peptide causes antibiotic-associated colitis. Proc Natl Acad Sci USA. 2014;111:13181–6.CrossRefPubMed
3.
go back to reference Zollner-Schwetz I, Hogenauer C, Joainig M, et al. Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clin Infect Dis. 2008;47:e74-8.CrossRefPubMed Zollner-Schwetz I, Hogenauer C, Joainig M, et al. Role of Klebsiella oxytoca in antibiotic-associated diarrhea. Clin Infect Dis. 2008;47:e74-8.CrossRefPubMed
4.
go back to reference Hogenauer C, Langner C, Beubler E, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med. 2006;355:2418–26.CrossRefPubMed Hogenauer C, Langner C, Beubler E, et al. Klebsiella oxytoca as a causative organism of antibiotic-associated hemorrhagic colitis. N Engl J Med. 2006;355:2418–26.CrossRefPubMed
5.
go back to reference Abboud B, El Hachem J, Yazbeck T, et al. Hepatic portal venous gas: physiopathology, etiology, prognosis and treatment. World J Gastroenterol. 2009;15:3585–90.CrossRefPubMedPubMedCentral Abboud B, El Hachem J, Yazbeck T, et al. Hepatic portal venous gas: physiopathology, etiology, prognosis and treatment. World J Gastroenterol. 2009;15:3585–90.CrossRefPubMedPubMedCentral
6.
go back to reference Liebman PR, Patten MT, Manny J, et al. Hepatic–portal venous gas in adults: etiology, pathophysiology and clinical significance. Ann Surg. 1978;187:281–7.CrossRefPubMedPubMedCentral Liebman PR, Patten MT, Manny J, et al. Hepatic–portal venous gas in adults: etiology, pathophysiology and clinical significance. Ann Surg. 1978;187:281–7.CrossRefPubMedPubMedCentral
7.
go back to reference Chan SC, Wan YL, Cheung YC, et al. Computed tomography findings in fatal cases of enormous hepatic portal venous gas. World J Gastroenterol. 2005;11:2953–5.CrossRefPubMedPubMedCentral Chan SC, Wan YL, Cheung YC, et al. Computed tomography findings in fatal cases of enormous hepatic portal venous gas. World J Gastroenterol. 2005;11:2953–5.CrossRefPubMedPubMedCentral
8.
go back to reference Fulwadhva UP, Wortman JR, Sodickson AD. Use of dual-energy CT and iodine maps in evaluation of bowel disease. Radiographics. 2016;36:393–406.CrossRefPubMed Fulwadhva UP, Wortman JR, Sodickson AD. Use of dual-energy CT and iodine maps in evaluation of bowel disease. Radiographics. 2016;36:393–406.CrossRefPubMed
9.
go back to reference Scrima A, Lubner MG, King S, et al. Value of MDCT and clinical and laboratory data for predicting the need for surgical intervention in suspected small-bowel obstruction. AJR Am J Roentgenol. 2017;208:785–93.CrossRefPubMed Scrima A, Lubner MG, King S, et al. Value of MDCT and clinical and laboratory data for predicting the need for surgical intervention in suspected small-bowel obstruction. AJR Am J Roentgenol. 2017;208:785–93.CrossRefPubMed
11.
go back to reference Potgens SA, Brossel H, Sboarina M, et al. Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction. Sci Rep. 2018;8:12321.CrossRefPubMedPubMedCentral Potgens SA, Brossel H, Sboarina M, et al. Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction. Sci Rep. 2018;8:12321.CrossRefPubMedPubMedCentral
12.
go back to reference Minnan L, Jinli H, Xiaobin W, et al. Isolation and characterization of a high H2-producing strain Klebsiella oxytoca HP1 from a hot spring. Res Microbiol. 2005;156:76–81.CrossRefPubMed Minnan L, Jinli H, Xiaobin W, et al. Isolation and characterization of a high H2-producing strain Klebsiella oxytoca HP1 from a hot spring. Res Microbiol. 2005;156:76–81.CrossRefPubMed
13.
go back to reference Wu X, Li Q, Dieudonne M, et al. Enhanced H2 gas production from bagasse using adhE inactivated Klebsiella oxytoca HP1 by sequential dark-photo fermentations. Bioresour Technol. 2010;101:9605–11.CrossRefPubMed Wu X, Li Q, Dieudonne M, et al. Enhanced H2 gas production from bagasse using adhE inactivated Klebsiella oxytoca HP1 by sequential dark-photo fermentations. Bioresour Technol. 2010;101:9605–11.CrossRefPubMed
14.
go back to reference Paasch C, Wilczek S, Strik MW. Liver abscess and sepsis caused by Clostridium perfringens and Klebsiella oxytoca. Int J Surg Case Rep. 2017;41:180–3.CrossRefPubMedPubMedCentral Paasch C, Wilczek S, Strik MW. Liver abscess and sepsis caused by Clostridium perfringens and Klebsiella oxytoca. Int J Surg Case Rep. 2017;41:180–3.CrossRefPubMedPubMedCentral
15.
go back to reference Bossuyt P, Verhaegen J, Van Assche G, et al. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis. 2009;3:4–7.CrossRefPubMed Bossuyt P, Verhaegen J, Van Assche G, et al. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis. 2009;3:4–7.CrossRefPubMed
16.
go back to reference Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–44.CrossRefPubMed Rodemann JF, Dubberke ER, Reske KA, et al. Incidence of Clostridium difficile infection in inflammatory bowel disease. Clin Gastroenterol Hepatol. 2007;5:339–44.CrossRefPubMed
Metadata
Title
Hepatic portal venous gas associated with Klebsiella oxytoca infection in the absence of preceding antibiotic treatment
Publication date
01-08-2019
Published in
Clinical Journal of Gastroenterology / Issue 4/2019
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-019-00947-1

Other articles of this Issue 4/2019

Clinical Journal of Gastroenterology 4/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.